August 27, 2021                                                           View this email in your browser

ALDA Senior Executive Conference: Join Us this October in California
We currently have over 100 executives registered to attend our Senior Executive Conference, taking place October 3-5 at the Montage at Laguna Beach. Thanks to those of you who have already registered; we look forward to seeing you in October! To register now and for more program information, click HERE.

We’ll be sending an email next week regarding the various precautions and health & safety measures that we will be implementing to ensure an outstanding experience for all attendees.
The topic for this event is The Proteomics Evolution: What’s New & What’s Next. Sessions will focus on the newest developments in this space, how companies are capitalizing on these opportunities, and the implications for ALDA member companies. Attendees will experience the top-tier sessions and networking you have come to expect at an ALDA event, including presentations from a host of outstanding speakers:
  • Chris Voss, a former international hostage negotiator for the FBI and best-selling author of Never Split the Difference: Negotiating As If Your Life Depended On It.
  • Proteomics Market Trends & Overview, presented by Puneet Souda with SVB Leerink
  • The Latest in Proteomics Applications & Forward-looking Research, presented by Jennifer van Eyk, PhD, Cedars Sinai
  • Proteomics 3.0, Machine Learning, and the Singularity, presented by John Yates III, PhD, Scripps Research
  • CEO Roundtable from Dynamic Proteomics Companies
      Confirmed Speakers: 
  • Omid Farokhzad, Chief Executive Officer and Chairman, Seer
  • Jon Heimer, CEO, Olink
  • Sujal Patel, CEO, Nautilus
  • Roy Smythe, CEO, SomaLogic
  • Moderator: Alex Vadas, Managing Director & Partner, Biopharmaceuticals & Life Sciences, L.E.K. Consulting,  
  • Michael Lewis, author of MoneyballThe Big ShortThe Blind Side, and the recent The Premonition: A Pandemic Story.
We look forward to seeing you in October!
Events Calendar


September 20
D&I Benchmarking Summary and Next Steps Webinar

October 3-5
2021 Fall Senior Executive Conference
Laguna Beach, CA

November 9
ALDA 2021 Virtual Service & Support Executives Conference

November 18
Breakfast Meeting at AMP
Philadelphia, PA

November 30
Regional Senior Executives Dinner
Boston, MA

May 1-3
2022 Spring Senior Executives Conference
Boston, MA

Welcome Our Six New Members!

Located in Massachusetts and Germany, BlueCatBio’s centrifugal Blue®Washer has become the new standard for non-contact media removal used by most top 25 pharma companies. Blue®Washer uses centrifugation to remove liquids from 96, 384 and 1536w plates, eliminating background and variability cellular assay data and eliminating tips from magnetic bead washes.
The official representative will be Founder & CEO Frank Feist and the alternate will be Wolfgang Mann, CEO and Founder.

Cytek Biosciences is a cell analysis solutions company headquartered in California. The company has developed a new generation of cell analysis tools and applications based on its full spectrum profiling (FSP) technology platform.
Wenbin Jiang, CEO will be the official representative and Allen Poirson, SVP, Corporate Development will be the alternate. 

Located in California Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human disease through its portfolio of market-leading companies and proprietary technologies. These companies are global leaders in providing products and services into the fields of nucleic acid production, biologics safety testing and protein detection to many of the world’s leading biopharma, vaccine, diagnostics and cell and gene therapy companies.
CEO Carl Hull will be the official representative and Doreen Pippen, VP Marketing will be the alternate. 

Personal Genome Diagnostics
is headquartered in Maryland. PGDx empowers the fight against cancer by unlocking actionable information from the genome. They are committed to improving clinical insight, speed of results, and healthcare economics by delivering a portfolio of regulated tissue-based and liquid biopsy genomic products for health systems worldwide.
Megan Bailey, CEO will be the official representative and Jamie Platt, COO will be the alternate.

Stilla Technologies is a Paris-based European Biotechnology company (with a Massachusetts presence) that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the naica® system.
Taking advantage of cutting-edge microfluidic innovations, Stilla® aims to make dPCR a lab commodity in all Life Sciences areas: research, therapeutics, and all the “omics”.

President and CEO Philippe Mourere will be the official representative and Matthew Grow, VP Global Marketing & Commercial Operations will be the alternate.

Headquartered in Massachusetts TetraScience provides the world’s first and only open R&D Data Cloud, with a mission to transform life sciences R&D, accelerate discovery, and improve human life.
Dr. Simon Meffan-Main, VP of Product will be the official representative and Dr. Alan Millar, VP of Business Development will be the alternate.
AACC Breakfast Update
In our last newsletter, we posted a save-the-date for a breakfast we would be hosting at AACC. Due to a number of circumstances, we will not hold this breakfast at this year’s event, but we do plan to be back at AACC 2022. We look forward to seeing you next year. Please let us know if you have any questions.
ALDA Website
ALDA Website
Traveling From Europe to the U.S.

Speaking of our fall event, we have been receiving questions related to the complexities of travel to the U.S. from European countries.

As you likely know, the travel ban into the U.S. remains in place and residents of Schengen nations are required to procure a National Interest Exemption (NIE) for travel to the United States. Much more information about this program and process is available here; it is recommended by most U.S. embassies that the application be submitted at least 3 weeks in advance of travel, so we wanted to give you ample time to submit. 

We have created a resource specific to this information HERE, including the latest on the NIE validity window, the parameters for acquiring an NIE from most European nations, and resources and tips shared by our members.

If you have any additional questions or if you would be willing to serve as a resource in this process for a fellow ALDA conference attendee, please reach out to ALDA President & CEO Mike Copps at
D&I Benchmarking Executive Summary Webinar
Join us on Monday, September 20 at 11:00 AM Eastern to learn more about our D&I Benchmarking survey results and the soon-to-be-released Executive Summary which will be sent out to all ALDA members.

Forty-five member companies participated in our first D&I Benchmarking survey and represented data on ~265,000 employees. Those member companies received the full report and a deep dive into the data in February however now all member companies are invited to join us to learn more about the soon to be released Executive Summary.

Pearl Meyer, our partners in conducting the survey, will share this data with attendees followed by the chair of ALDA’s DEI Task Force, Dan Shine with Thermo Fisher Scientific, discussing what steps ALDA plans to take next, including our next version of this survey.
The details are:

ALDA D&I Benchmarking Summary & Next Steps
Monday, September 20, 11:00 AM Eastern

Presented by:

Kathy Baron, Vice President, Pearl Meyer

Dan Shine, Senior Vice President and President, Analytical Instruments Group, Thermo Fisher Scientific
We hope that you will join us on September 20!
Save the Date: Boston Dinner Set for November 30
Our annual dinner for senior executives in the Boston and New England area returns on Tuesday, November 30. We are in the process of confirming our guest speaker and will let you know more details in the weeks ahead.
Our regional dinners present an informal opportunity to stay in contact with the senior leadership of other ALDA member companies outside of our semi-annual meetings, and to meet our newest members.
The dinners also present an opportunity to bring an executive or two who may not regularly attend our senior executive meetings and introduce them to the ALDA network.
The details of this year’s dinner are:
Date:               Tuesday, November 30
Time:               6:00 PM
Location:        Mistral Restaurant, 223
                        Columbus Ave.,
                        Boston, MA

Look for more information in your inbox in the coming weeks. Contact Carol Starke at for more information and to register for the dinner.
Save the Date: ALDA Breakfast at AMP 2021
Set for November 18

If your company is attending the AMP (Association for Molecular Pathology) 2021 Annual Meeting in Philadelphia, PA, please plan to attend our ALDA breakfast for senior executives on Thursday morning, November 18.
More information on the speaker, exact location, timing and registration will be shared in the near future.
We look forward to seeing you there!
Copyright © 2021 Analytical, Life Science & Diagnostics Association (ALDA), All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp